Navigation Links
Cellectis In-Licenses Induced Pluripotent Stem Cell Technology From iPS Academia Japan
Date:10/18/2010

PARIS and KYOTO, Japan, Oct. 18 /PRNewswire/ -- Cellectis (Alternext: ALCLS), the French genome engineering specialist, and iPS Academia Japan Inc. (Kyoto, Japan) announced today that they have signed two separate non-exclusive agreements granting Cellectis worldwide access to the induced Pluripotent Stem (iPS) cells patent portfolio arising from the work of Professor Shinya Yamanaka, MD, Ph.D., Center for iPS Cell Research and Application (CiRA) at the University of Kyoto, Japan.

The agreements allow Cellectis and its affiliates to research, develop and commercialize both research tools (covered by one agreement) and human therapeutics or prophylactics (covered by the second agreement) derived from iPS cells, in a certain range of differentiated cell lineages. Cellectis is the first company worldwide to be licensed by iPS Academia Japan under this iPS cell patent portfolio for human therapeutics and prophylactics. In the research tool field, this is the first agreement with French company following agreements with US and German companies.  

In 2006, Prof. Shinya Yamanaka and his colleagues first described the process by which iPS cells - somatic cells that have been reprogrammed to behave like embryonic stem cells - can differentiate into any other cell type. This breakthrough research has provided the scientific community with the tools to generate an endless source of stem cells. Importantly, iPS cells are not associated with the ethical issues attendant to embryonic cells.

Cellectis' unique genome engineering expertise and technology allows precise and reproducible targeted modifications in the genome of living cells and organisms. The iPS cell technologies will be used by Cellectis, and Ectycell, its subsidiary focused on industrial applications of iPS cells, to engineer these cells and derive consistent lines of robust products both as tools and as therapeutics.

"These agreements provide Cellectis with a powerful combin
'/>"/>

SOURCE Cellectis
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. New Study Shows Meganuclease-Driven Targeted Integration Using Cellectis bioresearchs cGPS® CHO-K1 Kit to be Highly Efficient for Drug Discovery
2. Cellectis Bioresearch and Cedarlane Join Forces for the Distribution of cGPS® and cGPS® Custom Kits in Canada
3. Cellectis bioresearch and Helix Biocon Join Forces for the Promotion of cGPS® and cGPS® Custom Kits and Cell Line Engineering Services in India
4. Cellectis bioresearch Announces Establishment of Subsidiary in the US
5. Cellectis Publishes Its Financial Statement for the First Half of 2010
6. Cerenis Therapeutics In-Licenses Intellectual Property for New Treatment of Aortic Valve Stenosis
7. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
8. Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
9. Intradigm Study Shows Ability of siRNAs Systemically Delivered With TargeTran(TM) System to Suppress Tumor-Induced Angiogenesis in Mice
10. FORTEO(R) Increased Spine Bone Mineral Density in Patients with Glucocorticoid-Induced Osteoporosis
11. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... HILL, N.C. , Nov. 21, 2014 /PRNewswire/ ... healthcare system. Undoubtedly, the growing influence of patients ... spend for marketing interactions. Now, more than ever, ... retain patients for medical products is essential. ... firm, Best Practices, LLC, benchmarked companies spent about ...
(Date:11/21/2014)... SAN CLEMENTE, Calif. , Nov. 21, 2014 /PRNewswire/ ... Lab Coats and Performance Scrubs carried out a new ... the medical industry,s very first "limited edition" lab ... the first female professors of surgery in the world. ... departure from its unisex predecessors, with a sleek envelope ...
(Date:11/21/2014)... 2014  PTC Therapeutics, Inc. (NASDAQ: PTCT ) ... Award for Vision, Innovation, and Leadership has been awarded to ... award recognizes an individual who has had a significant impact ... for several decades. "I am honored to ... Peltz , Ph.D., CEO of PTC Therapeutics, Inc. "When I ...
Breaking Medicine Technology:New Report Details Importance of Adopting a "Patient Journey" Framework in Marketing 2Medelita Introduces Medical Industry's First Limited Edition Women's Designer Lab Coat 2PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 2PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 3
(Date:11/22/2014)... FRIDAY, Nov. 21, 2014 (HealthDay News) -- Many young ... smoke, but a new study finds fumes from the ... been linked to an increased risk for leukemia in ... 21 in the journal Cancer Epidemiology, Biomarkers & ... hookah tobacco smoking is not a safe alternative to ...
(Date:11/22/2014)... Steven Reinberg HealthDay Reporter ... better when patients are treated in an ambulance by a ... researchers report. The sooner patients get the clot dissolver ... after a stroke, the researchers noted. For the best outcome, ... after stroke symptoms start, the researchers said. "The so-called ...
(Date:11/22/2014)... HealthDay Reporter FRIDAY, Nov. 21, ... homes may commonly deal with aggressive or inappropriate behavior from ... 10 centers in New York state found that, in the ... were involved in some type of incident with a fellow ... someone yelling or cursing at another resident. In other cases, ...
(Date:11/21/2014)... Los Angeles, CA (PRWEB) November 21, 2014 ... is now creating picture-perfect smiles for patients in preparation ... are bonded to the fronts of teeth, look completely ... flaws. In certain situations, veneers are also valued for ... for most patients and can be used on one ...
(Date:11/21/2014)... 2014 (HealthDay News) -- Seeking to make it tougher ... and Drug Administration on Thursday approved a new hydrocodone ... -- best known by the brand name Vicodin -- ... to a surge in dangerous addictions across the United ... ER (hydrocodone bitartrate) is an extended-release tablet to treat ...
Breaking Medicine News(10 mins):Health News:Hookahs Deliver Toxic Benzene in Every Puff, Study Shows 2Health News:Special Ambulance Delivers Vital Stroke Care More Quickly 2Health News:Special Ambulance Delivers Vital Stroke Care More Quickly 3Health News:Senior-to-Senior Aggression Common in U.S. Nursing Homes 2Health News:Senior-to-Senior Aggression Common in U.S. Nursing Homes 3Health News:Los Angeles Porcelain Veneers Dentist, Dr. Kevin Sands, Now Creates Picture-Perfect Smiles for Patients for the Holiday Season 2Health News:FDA Approves 'Abuse-Resistant' Narcotic Painkiller 2Health News:FDA Approves 'Abuse-Resistant' Narcotic Painkiller 3
... A study has indicated that inflammatory bowel disease in women ... two times.// , ,Diseases such as Crohn's disease and ... weight babies or premature babies. Yet, the 'silver lining' exists ... has certainly reduced the risks. ,The St. ...
... by a US research company has highlighted the overriding ... health// problem facing society and their children today. , ... adults, found that nearly 27% named 'obesity', as the ... followed next with 16% strongly advocating action, while ...
... that could be used as a bioterrorist tool eludes ... better understood, University of Iowa// researchers report in the ... ,This bacterium, Francisella tularensis, is found naturally in ... insect bites, contact with infected rabbits or ingesting contaminated ...
... Food Technology Plant Special Research Centre (CeRPTA) is a ... called as gluten sensitive enteropathy. This product was successfully ... enhanced nutritive value and increased shelf life. ... sufferers to follow a strictly gluten-free diet for their ...
... of Texas M. D. Anderson Cancer Center suggest that the ... 40 years reduced the tumor growth in the// human pancreas ... ,The Journal of the National Cancer Institute issued on Dec.20 ... is three times more effective than just the administration of ...
... resonance imaging technique developed at the University of ... of neurological problems, such as// Chiari malformations, hydrocephalus ... use through a $1.4 million National Institutes of ... project, which draws on bioengineering, radiology and neurosurgery, ...
Cached Medicine News:Health News:Clues Found On How Deadly Bacterium Gains Foothold 2Health News:Clues Found On How Deadly Bacterium Gains Foothold 3Health News:Gluten Free Bread: Boon for Celiac Disease 2Health News:Anti Allergy Drugs Reduce Tumor Growth 2Health News:Anti Allergy Drugs Reduce Tumor Growth 3Health News:New MRI Technique Measures Intracranial Pressure in Brain Disorder 2
For the quantitative in vitro determination of Lipase in human serum and plasma....
Enzymatic Clearance assay for the in vitro quantitative determination of HDL-cholesterol in human serum and plasma....
For the quantitative in vitro determination of Ammonia in plasma...
For the quantitative in vitro determination of Potassium in serum or plasma....
Medicine Products: